Replies to post #896 on Bioxytran Inc (BIXT)

[Ecomike]

$BIXT may start singing a new tune as Season 3 of "Its not just the flu" plays out in China and the US Hospitals in early January.

[Ecomike]

$BIXT is the only antiviral that eliminates 100% of Covid19 in 3 days. But it needs time to brew and age (the major drug Trials....). The first trial was 100% success, ZERO covid left after 3 days in the body. IV dosed....

.40 is the floor, and sooner or latter it will rip short to medium term.

I do not know when it will rip, but the news is spreading on LinkedIn and at $500/per person investment work shops...

In 3 years $BIXT could be a retirement stock. I have looked at the bio-chemistry on the $BIXT Carbohydrate Galectins.

In my professional opinion, They are destined to spawn an entire generation of new non toxic antivirals this decade, that can reduce the risk of lingering virus triggered cancers. It can be customized to target Every known virus, one virus at a time, like Moderna is doing with its so called vaccines, that are actually just immune booster targeting boosters, and not true Polio style vaccines.

But it is not a day trade 1-2 day stock. It is, IMO, a good ethical investment, and sooner or later a major retirement stock, IMO. But it will be a cash burner, short term...like all of these early stage firms, With the drug trials... I do suspect they may be fully funded short-medium term, and news may drop any day, so this may be a good time to buy. Support looks solid chart wise, and over sold. We will see in the next filings.

That said, news from left field of JV deals with funding, Analyst articles, and road show investment work shops can bring in new buyers, and unlike most OTC stocks, the $BIXT VP of Marketing is a seasoned expert Bio-Tech drug company analyst... Never seen that on an OTC drug start up before... Got wonder if he is waking up the Big boys that might one day co-fund major trials for other Non-covid19 viruses....

The future potential for JV funded by major drug firms, development and trials for antivirals for other viruses is a real possibility too, that could happen and give the retail share price a real boost..

I will adding to my shares going forward...